Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
31
1
3
4
5
6
7
12:00 AM - Heart Ailments
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
25
26
27
28
29
30
1
2
3
Diabetes, Obesity and Its Complications
2021-09-02 - 2021-09-03    
All Day
Diabetes Congress 2021 aims to provide a platform to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial [...]
Heart Ailments
2021-09-07 - 2021-09-08    
All Day
International conference and Expo on Heart Ailments Webinar held at Zoom or WebEx online on September 07-08, 2021. The conference is concentrated on the theme [...]
Computer Graphics & Animation 2021
2021-09-24 - 2021-09-25    
All Day
Computer graphics is branch of Computer Science and Technology It’s a graphical pattern of an image or objects which created by using specific software and [...]
Events on 2021-09-02
Events on 2021-09-07
Heart Ailments
7 Sep 21
Events on 2021-09-24
Latest News

Canadian Healthcare Software Provider PointClickCare Plans

plans

PointClickCare, a Canadian health-care software provider, filed for an initial public offering in the U.S. and plans to do the same in Canada.

The Mississauga, Ontario-based company plans to list on the Nasdaq Stock Market under the stock symbol PCLK, and intends to go public on the Toronto Stock Exchange as PCC, according to the prospectus and a statement filed Thursday.

PointClickCare is one of a wave of Canadian tech companies beginning to tap public markets. E-commerce software maker Shopify Inc. has increased about 60 per cent in U.S. trading since its listing in May. Hootsuite Media Inc. has said it could go public by the end of 2016 and Vision Critical Communications Inc. is weighing the sale of part of its business ahead of a possible IPO early next year, according to people familiar with the process.

PointClickCare’s IPO is being arranged by JPMorgan Chase & Co., Goldman Sachs Group, Royal Bank of Canada, William Blair & Co. and Canaccord Genuity Group Inc.

The company plans to use the proceeds for working capital and general proceeds, to repay debt and cover a special dividend to shareholders of about $17.5-million before the close of the offering.